ARRAY BIOPHARMA
   
 

Welcome to Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory and metabolic diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas.

Latest News and Press Releases:
11/2/2009 Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2010
10/28/2009 Array BioPharma to Report Financial Results for the First Quarter of Fiscal 2010 on November 2, 2009
10/1/2009 Array BioPharma to Present Clinical Results on Diabetes Drug at European Diabetes Meeting
9/18/2009 Array BioPharma Enters into Equity Distribution Agreement
 
Email this page
Printer friendly version
   

Array BioPharma Reports Positive Results Of Its Oral Glucokinase Activator In Type 2 Diabetes Patients

Press Release

Slides